Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
Fiat Chrysler and France's Renault could soon partner up to take on the sweeping changes to the global auto industry, according to a report in the Financial Times. The...Autosread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
Walgreens will stock the Auvi-Q as an EpiPen shortage has left some pharmacies unable to fill prescriptions of the lifesaving allergy treatment, leaving some parents scrambling.
Like EpiPen, the Auvi-Q delivers epinephrine to treat severe allergic reactions. The small rectangular auto-injector walks people through its use. Drugmaker Kaleo's partnership with Walgreens will be the first time the Auvi-Q has been available at retail pharmacies. Currently, patients can only receive the devices through the mail.
The Auvi-Q's introduction to Walgreens comes as manufacturing disruptions have led to an EpiPen shortage. Drugstores across the country have no or very few EpiPens in stock. It's especially frustrating for parents who are trying to stock up and send their children back to school with a fresh supply of medication.
Auvi-Q's list price is $4,500 for two auto-injectors. Kaleo, a privately held company, said eligible patients with commercial insurance, even those with high deductible plans or whose insurers don't cover the Auvi-Q, can obtain it at no cost.
People without insurance whose household income is less than $100,000 can get the Auvi-Q for free through an assistance program.
"We are working with insurance providers to maximize coverage of AUVI-Q for as many patients as possible," Phil Rackliffe, general manager of Allergy and Pediatrics at Kaleo, said in a statement.
Mylan markets EpiPen, while Pfizer manufacturers it. Supply issues started in May, but the school year has added more pressure to the situation. Amneal Pharmaceuticals, which makes the Adrenaclick, has also faced manufacturing issues this year. Pfizer also produces that drug.
The Food and Drug Administration approved a generic version of EpiPen last month. Its producer, Teva, said it would launch the drug "in the coming months" but didn't specify a date when announcing its approval.
Patients who can't fill their epinephrine prescriptions can work with Walgreens pharmacists and their doctor to see if the Auvi-Q is appropriate for them.
"Walgreens pharmacists continue to care for and work with patients and their prescribers to ensure they have access to the epinephrine auto-injectors they need, and we're pleased to work with kaléo to help meet the demand for epinephrine auto-injectors across the country," Walgreens President of Operations Richard Ashworth said in a statement.
-CNBC's Meg Tirrell contributed to this report